|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> ABT-888>> 市场分析报告 |
ABT-888市场分析报告 |
|
CAS 912445-05-7 ABT-888 Chemical Report & Database CAS 912445-05-7 ABT-888 Chemical Report & Database This ABT-888 Chemical World ... The ABT-888 World Consumption Report & Database definitions: Name: ABT-888: ABT-888; 2-[(2R)-2-Methyl ... Chemical or Reaction Intermediate The ABT-888 Report & Database gives Market ... Ovarian Cancer [2017] ... list now > Phase III Veliparib (ABT-888; AbbVie) Atezolizumab (Tecentriq; Roche) Avelumab ... Colorectal Cancer [2017] ... (Vaccinogen) Early Stage MOAs (P1/P2) Veliparib (ABT-888; AbbVie) Entinostat (Syndax Pharmaceuticals) SYM004 ... Ovarian Cancer: KOL Insight ... ; Roche) Phase III Therapies Veliparib (ABT-888; AbbVie Atezolizumab (Tecentriq; Roche) Avelumab ... Non-Small Cell Lung Cancer: KOL Insight Non-Small Cell Lung Cancer: KOL Insight offers detailed expert opinion on the continuing evolution of the treatment paradigm for EGFR/ALK positive and negative NSCLC, and the potential for targeting KRAS-mutation positive disease. The treatment of advanced ... Breast Cancer: New targeted therapies transform treatment - KOL Insight The introduction of targeted therapies revolutionised the breast cancer market, widening clinical options and bringing improved survival rates and lower side effects for patients. Now the sector is set for further positive change and expansion as next ... Breast Cancer: KOL Insight [2018] ... ) Zejula (niraparib; Tesaro/Merck & Co.) veliparib (ABT 888; AbbVie) Keytruda (pembrolizumab; Merck & Co.) Tecentriq ... |